A TNF receptor 2 selective agonist rescues human neurons from oxidative stress-induced cell death

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Fischer, Roman ^a   Maier, Olaf ^a   Siegemund, Martin ^a   Wajant, Harald ^b   Scheurich, Peter ^a   Pfizenmaier, Klaus ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; HYDROGEN PEROXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; TENASCIN; TUMOR NECROSIS FACTOR INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR 2; HYBRID PROTEIN; NEUROPROTECTIVE AGENT; SUPEROXIDE;

ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NERVE CELL; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; ANIMAL; CELL DIFFERENTIATION; CELL STRAIN HEK293; CHEMISTRY; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; ENZYME SPECIFICITY; GENE EXPRESSION REGULATION; METABOLISM; SOLUBILITY;

ANIMALS; CELL DEATH; CELL DIFFERENTIATION; DOPAMINERGIC NEURONS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; MICE; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SOLUBILITY; SUBSTRATE SPECIFICITY; SUPEROXIDES; TENASCIN;

EID: 81055124816     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027621     Document Type: Article

References (44)

1. Wajant H, Pfizenmaier K, Scheurich P, (2003) Tumor necrosis factor signaling. Cell Death Differ 10: 45-65.
2. McCoy MK, Tansey MG, (2008) TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation 5: 45.
3. Pfizenmaier K, Szymkowski DE, (2011) Workshop Summary: Introduction to Rational Design of New Means for Therapeutic Modulation of Function of the TNF Family. Adv Exp Med Biol 691: 487-491.
4. Amor S, Puentes F, Baker D, van der Valk P, (2010) Inflammation in neurodegenerative diseases. Immunology 129: 154-169.
5. Anonymous, (1999) TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology 53: 457-465.
6. Faustman D, Davis M, (2010) TNF receptor 2 pathway: drug target for autoimmune diseases. Nat Rev Drug Discov 9: 482-493.
7. Marchetti L, Klein M, Schlett K, Pfizenmaier K, Eisel UL, (2004) Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J Biol Chem 279: 32869-32881.
8. Dolga AM, Granic I, Blank T, Knaus HG, Spiess J, et al. (2008) TNF-alpha-mediates neuroprotection against glutamate-induced excitotoxicity via NF-kappaB-dependent up-regulation of K2.2 channels. J Neurochem 107: 1158-1167.
9. Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfizenmaier K, et al. (2002) Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 22: RC216.
10. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, et al. (2001) TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4: 1116-1122.
11. Akassoglou K, Bauer J, Kassiotis G, Pasparakis M, Lassmann H, et al. (1998) Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol 153: 801-813.
12. Loetscher H, Stueber D, Banner D, Mackay F, Lesslauer W, (1993) Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. J Biol Chem 268: 26350-26357.
13. Krippner-Heidenreich A, Grunwald I, Zimmermann G, Kuhnle M, Gerspach J, et al. (2008) Single-chain TNF, a TNF derivative with enhanced stability and antitumoral activity. J Immunol 180: 8176-8183.
14. Boschert V, Krippner-Heidenreich A, Branschadel M, Tepperink J, Aird A, et al. (2010) Single chain TNF derivatives with individually mutated receptor binding sites reveal differential stoichiometry of ligand receptor complex formation for TNFR1 and TNFR2. Cell Signal 22: 1088-1096.
15. Grell M, Douni E, Wajant H, Lohden M, Clauss M, et al. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793-802.
16. Rauert H, Wicovsky A, Muller N, Siegmund D, Spindler V, et al. (2010) Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2). J Biol Chem 285: 7394-7404.
17. Lotharius J, Barg S, Wiekop P, Lundberg C, Raymon HK, et al. (2002) Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J Biol Chem 277: 38884-38894.
18. Lotharius J, Falsig J, van Beek J, Payne S, Dringen R, et al. (2005) Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci 25: 6329-6342.
19. Schildknecht S, Poltl D, Nagel DM, Matt F, Scholz D, et al. (2009) Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells. Toxicol Appl Pharmacol 241: 23-35.
20. Scholz D, Poltl D, Genewsky A, Weng M, Waldmann T, et al. (2011) Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line. J Neurochem.
21. Krippner-Heidenreich A, Tubing F, Bryde S, Willi S, Zimmermann G, et al. (2002) Control of receptor-induced signaling complex formation by the kinetics of ligand/receptor interaction. J Biol Chem 277: 44155-44163.
22. Grell M, Scheurich P, Meager A, Pfizenmaier K, (1993) TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine Cytokine Res 12: 143-148.
23. Fischer R, Maier O, Naumer M, Krippner-Heidenreich A, Scheurich P, et al. (2011) Ligand-induced internalization of TNF receptor 2 mediated by a di-leucin motif is dispensable for activation of the NFkappaB pathway. Cell Signal 23: 161-170.
24. Nicholson KM, Anderson NG, (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14: 381-395.
25. Noshita N, Lewen A, Sugawara T, Chan PH, (2002) Akt phosphorylation and neuronal survival after traumatic brain injury in mice. Neurobiol Dis 9: 294-304.
26. Gary DS, Mattson MP, (2001) Integrin signaling via the PI3-kinase-Akt pathway increases neuronal resistance to glutamate-induced apoptosis. J Neurochem 76: 1485-1496.
27. Yano S, Morioka M, Fukunaga K, Kawano T, Hara T, et al. (2001) Activation of Akt/protein kinase B contributes to induction of ischemic tolerance in the CA1 subfield of gerbil hippocampus. J Cereb Blood Flow Metab 21: 351-360.
28. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, et al. (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65: 135-172.
29. Grell M, Zimmermann G, Gottfried E, Chen CM, Grunwald U, et al. (1999) Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J 18: 3034-3043.
30. Wallach D, Engelmann H, Nophar Y, Aderka D, Kemper O, et al. (1991) Soluble and cell surface receptors for tumor necrosis factor. Agents Actions Suppl 35: 51-57.
31. Holler N, Tardivel A, Kovacsovics-Bankowski M, Hertig S, Gaide O, et al. (2003) Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol Cell Biol 23: 1428-1440.
32. Bergman H, Deuschl G, (2002) Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back. Mov Disord 17 (Suppl 3): S28-40.
33. Olanow CW, (1993) A radical hypothesis for neurodegeneration. Trends Neurosci 16: 439-444.
34. Richardson JS, (1993) Free radicals in the genesis of Alzheimer's disease. Ann N Y Acad Sci 695: 73-76.
35. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, et al. (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci U S A 88: 10540-10543.
36. Richter C, Kass GE, (1991) Oxidative stress in mitochondria: its relationship to cellular Ca2+ homeostasis, cell death, proliferation, and differentiation. Chem Biol Interact 77: 1-23.
37. Whittemore ER, Loo DT, Cotman CW, (1994) Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons. Neuroreport 5: 1485-1488.
38. Whittemore ER, Loo DT, Watt JA, Cotman CW, (1995) A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture. Neuroscience 67: 921-932.
39. Lotharius J, Dugan LL, O'Malley KL, (1999) Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci 19: 1284-1293.
40. Barnum CJ, Tansey MG, (2010) Modeling neuroinflammatory pathogenesis of Parkinson's disease. Prog Brain Res 184: 113-132.
41. Yabe T, Wilson D, Schwartz JP, (2001) NFkappaB activation is required for the neuroprotective effects of pigment epithelium-derived factor (PEDF) on cerebellar granule neurons. J Biol Chem 276: 43313-43319.
42. Datta SR, Brunet A, Greenberg ME, (1999) Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927.
43. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, et al. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-1321.
44. Jordan J, Galindo MF, Tornero D, Gonzalez-Garcia C, Cena V, (2004) Bcl-x L blocks mitochondrial multiple conductance channel activation and inhibits 6-OHDA-induced death in SH-SY5Y cells. J Neurochem 89: 124-133.